TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 234 filers reported holding TG THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,620 | -22.0% | 3,543 | +131.7% | 0.00% | – |
| Q2 2023 | $37,980 | +57.4% | 1,529 | -4.7% | 0.00% | – |
| Q1 2023 | $24,124 | +116.0% | 1,604 | +69.9% | 0.00% | – |
| Q4 2022 | $11,168 | +39.6% | 944 | -29.8% | 0.00% | – |
| Q3 2022 | $8,000 | +60.0% | 1,344 | +9.4% | 0.00% | – |
| Q2 2022 | $5,000 | -50.0% | 1,228 | +7.2% | 0.00% | – |
| Q1 2022 | $10,000 | -50.0% | 1,146 | +1.9% | 0.00% | – |
| Q4 2021 | $20,000 | -73.7% | 1,125 | -51.1% | 0.00% | – |
| Q3 2021 | $76,000 | -14.6% | 2,299 | +0.3% | 0.00% | – |
| Q2 2021 | $89,000 | +74.5% | 2,293 | +116.3% | 0.00% | – |
| Q1 2021 | $51,000 | -13.6% | 1,060 | -7.2% | 0.00% | – |
| Q4 2020 | $59,000 | +118.5% | 1,142 | +13.6% | 0.00% | – |
| Q3 2020 | $27,000 | +170.0% | 1,005 | +0.5% | 0.00% | – |
| Q1 2020 | $10,000 | -9.1% | 1,000 | 0.0% | 0.00% | – |
| Q4 2019 | $11,000 | +175.0% | 1,000 | +66.7% | 0.00% | – |
| Q3 2018 | $4,000 | -50.0% | 600 | 0.0% | 0.00% | – |
| Q2 2018 | $8,000 | -63.6% | 600 | -62.5% | 0.00% | – |
| Q1 2018 | $22,000 | +450.0% | 1,600 | +166.7% | 0.00% | – |
| Q4 2017 | $4,000 | -50.0% | 600 | 0.0% | 0.00% | – |
| Q3 2017 | $8,000 | +33.3% | 600 | 0.0% | 0.00% | – |
| Q2 2017 | $6,000 | 0.0% | 600 | 0.0% | 0.00% | – |
| Q1 2017 | $6,000 | +200.0% | 600 | 0.0% | 0.00% | – |
| Q4 2016 | $2,000 | -89.5% | 600 | -76.9% | 0.00% | – |
| Q3 2016 | $19,000 | +11.8% | 2,600 | -7.5% | 0.00% | – |
| Q2 2016 | $17,000 | -32.0% | 2,810 | -0.3% | 0.00% | – |
| Q1 2016 | $25,000 | -28.6% | 2,818 | +0.1% | 0.00% | – |
| Q4 2015 | $35,000 | +1650.0% | 2,814 | +1215.0% | 0.00% | – |
| Q3 2015 | $2,000 | -94.4% | 214 | -90.3% | 0.00% | – |
| Q2 2015 | $36,000 | +1700.0% | 2,207 | +1724.0% | 0.00% | – |
| Q1 2015 | $2,000 | 0.0% | 121 | 0.0% | 0.00% | – |
| Q4 2014 | $2,000 | – | 121 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 726,200 | $3,086,000 | 3.46% |
| Paradigm Biocapital Advisors LP | 1,964,709 | $8,350,000 | 1.66% |
| 683 Capital Management, LLC | 3,300,000 | $14,025,000 | 0.99% |
| MAVERICK CAPITAL LTD | 6,747,549 | $28,677,000 | 0.71% |
| Antara Capital LP | 1,500,000 | $6,375,000 | 0.27% |
| Parkwood LLC | 47,168 | $1,375,000 | 0.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,677,500 | $11,379,000 | 0.24% |
| PURA VIDA INVESTMENTS, LLC | 950,813 | $4,041,000 | 0.24% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 567,576 | $2,412,000 | 0.20% |
| Antara Capital LP | 900,000 | $3,825,000 | 0.16% |